Diurnal mood variation symptoms in major depressive disorder associated with evening chronotype: Evidence from a neuroimaging study

被引:0
|
作者
Chen, Zhilu [1 ]
Zhao, Shuai [1 ]
Tian, Shui [2 ]
Yan, Rui [1 ,3 ]
Wang, Huan [2 ]
Wang, Xumiao [1 ]
Zhu, Rongxin [1 ]
Xia, Yi [1 ]
Yao, Zhijian [1 ,2 ,3 ]
Lu, Qing [2 ,4 ]
机构
[1] Nanjing Med Univ, Affiliated Brain Hosp, Dept Psychiat, Nanjing 210029, Jiangsu, Peoples R China
[2] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China
[3] Nanjing Univ, Sch Med, Nanjing Brain Hosp, Nanjing 210093, Jiangsu, Peoples R China
[4] Key Lab Minist Educ, Child Dev & Learning Sci, Nanjing 210096, Jiangsu, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Major depressive disorder; Diurnal mood variation; Resting state functional magnetic resonance imaging; Chronotype;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Major depressive disorder (MDD) is often accompanied with classic diurnal mood variation (DMV) symptoms. Patients with DMV symptoms feel a mood improvement and prefer activities at dusk or in the evening, which is consistent with the evening chmnotype. Their neural alterations are unclear. In this study, we aimed to explore the neuropathological mechanisms underlying the circadian rhythm of mood and the association with chronotype in MDD. Methods: A total of 126 depressed patients, including 48 with DMV, 78 without, and 67 age/gender-matched healthy controls (HC) were recruited and underwent a resting-state functional magnetic resonance imaging. Spontaneous neural activity was investigated using amplitude of low-frequency fluctuation (ALFF) and region of interest (ROD-based functional connectivity (FC) analyses were conducted. The Morningness-Eveningness Questionnaire (MEQ) was utilized to evaluate participant chronotypes and Pearson correlations were calculated between altered ALFF/FC values and MEQ scores in patients with MDD. Results: Compared with NMV, DMV group exhibited lower MEQ scores, and increased ALFF values in the right orbital superior frontal gyms (oSFG). We observed that increased FC between the left suprachiasmatic nucleus (SCN) and supramarginal gyrus (SMG). ALFF in the oSFG and FC of rSCN-SMG were negatively correlated with MEQ scores. Limitation: Some people's chronotypes information is missing. Conclusion: Patients with DMV tended to be evening type and exhibited abnormal brain functions in frontal lobes. The synergistic changes between frontotemporal lobe, SCN-SMG maybe the characteristic of patients with DMV symptoms.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 50 条
  • [21] Evidence against mood-congruent attentional bias in Major Depressive Disorder
    Cheng, Philip
    Preston, Stephanie D.
    Jonides, John
    Mohr, Alicia Hofelich
    Thummala, Kirti
    Casement, Melynda
    Hsing, Courtney
    Deldin, Patricia J.
    PSYCHIATRY RESEARCH, 2015, 230 (02) : 496 - 505
  • [22] Are youths with disruptive mood dysregulation disorder different from youths with major depressive disorder or persistent depressive disorder?
    Benarous, Xavier
    Renaud, Johanne
    Breton, Jean Jacques
    Cohen, David
    Labelle, Real
    Guile, Jean-Marc
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 265 : 207 - 215
  • [23] Insular dysfunction of interoception in major depressive disorder: from the perspective of neuroimaging
    Hu, Lan
    He, Hui
    Roberts, Neil
    Chen, Jiajia
    Yan, Guojian
    Pu, Li
    Song, Xufeng
    Luo, Cheng
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [24] Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms
    Rapinesi, Chiara
    Janiri, Delfina
    Kotzalidis, Georgios D.
    Serata, Daniele
    Del Casale, Antonio
    Scatena, Paola
    Dacquino, Claudia
    Gentile, Giovanna
    Manfredi, Giovanni
    Danese, Emanuela
    Raccah, Ruggero Nessim
    Brugnoli, Roberto
    Callovini, Gemma
    Ferri, Vittoria Rachele
    Ferracuti, Stefano
    Zangen, Abraham
    Simmaco, Maurizio
    Angeletti, Gloria
    Girardi, Paolo
    GENERAL HOSPITAL PSYCHIATRY, 2015, 37 (03) : 274.e7 - 274.e9
  • [25] Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers witha history of major depressive disorder
    Kahler, CW
    Brown, RA
    Ramsey, SE
    Niaura, R
    Abrams, DB
    Goldstein, MG
    Mueller, TI
    Miller, IW
    JOURNAL OF ABNORMAL PSYCHOLOGY, 2002, 111 (04) : 670 - 675
  • [26] Towards continuous monitoring of depressive mood from locomotor activity in major depressive disorder
    Kim, Jinhyuk
    Nakamura, Toru
    Kikuchi, Hiroe
    Yoshiuchi, Kazuhiro
    Sasaki, Tsukasa
    Yamamoto, Yoshiharu
    Transactions of Japanese Society for Medical and Biological Engineering, 2014, 52
  • [27] Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder
    Freeman, Marlene P.
    Fava, Maurizio
    Gommoll, Carl
    Chen, Changzheng
    Greenberg, William M.
    Ruth, Adam
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (02) : 100 - 109
  • [28] MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder
    Qi, Shile
    Yang, Xiao
    Zhao, Liansheng
    Calhoun, Vince D.
    Perrone-Bizzozero, Nora
    Liu, Shengfeng
    Jiang, Rongtao
    Jiang, Tianzi
    Sui, Jing
    Ma, Xiaohong
    BRAIN, 2018, 141 : 916 - 926
  • [29] Neural biomarker of functional disability in major depressive disorder: A structural neuroimaging study
    Zhou, Rubai
    Chen, Jun
    Zhao, Guoqing
    Wang, Zuowei
    Peng, Daihui
    Xia, Weiping
    Mao, Ruizhi
    Xu, Jingjing
    Wang, Fan
    Zhang, Chen
    Wang, Yong
    Yuan, Chengmei
    Su, Yousong
    Huang, Jia
    Yang, Tao
    Wang, Chenglei
    Cui, Lvchun
    Wang, Jijun
    Palaniyappan, Lena
    Fang, Yiru
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 111
  • [30] The Effect of Electroconvulsive Therapy on Emotional Processing in Major Depressive Disorder: A Neuroimaging Study
    Argyelan, Miklos
    Kaliora, Styliani
    Hanna, Harlington
    Ikuta, Toshikazu
    Kingsley, Peter B.
    Sarpal, Deepak
    Szeszko, Philip R.
    Malhotra, Anil
    Petrides, Georgios
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S174 - S174